PRP19 Enhances Esophageal Squamous Cell Carcinoma Progression by Reprogramming SREBF1-Dependent Fatty Acid Metabolism.

Guang-Cong Zhang Xiang-Nan Yu Hong-Ying Guo Jia-Lei Sun Zhi-Yong Liu Ji-Min Zhu Tao-Tao Liu Ling Dong Xi-Zhong Shen Jie Yin

Published in: Cancer research (2023)

Upregulation of pre-mRNA processing factor 19 (PRP19) contributes to esophageal squamous cell carcinoma progression by reprogramming SREBF1-dependent fatty acid metabolism, identifying PRP19 as a potential prognostic biomarker and therapeutic target.

Keyphrases

fatty acid
platelet rich plasma
cell proliferation
poor prognosis
signaling pathway
binding protein
risk assessment
human health